首页 > 最新文献

Lymphology最新文献

英文 中文
Defocused and Radial Shock Wave Therapy, Mesotherapy, and Kinesio Taping Effects in Patients with Lipedema: A Pilot Study. 脂肪性水肿患者的聚焦和径向冲击波疗法、中胚层疗法和肌动贴效果:试点研究
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-11-29 DOI: 10.2458/lymph.5872
S. Michelini, F. Musa, M. Vetrano, F. Santoboni, S. M. Nusca, E. Latini, D. Trischitta, S. Michelini, M. Iosa, M. Vulpiani
The aim of this pilot study was to investigate the effects of defocused and radial shock wave therapy, mesotherapy, and kinesio taping on pain, circumferences of lower limbs, echographic/ elastosonographic pattern of subcutaneous adipose tissue (SAT), and quality of life in patients with lipedema. Fifteen women affected by lower limb lipedema in stage II were treated with shock wave therapy, mesotherapy, and kinesio taping on thighs and legs (eight sessions, twice a week). The primary outcome was pain, as assessed by Numeric Rating Scale (NRS). Secondary outcomes included the limb circumferences measurements, the SF-12 Health Survey for quality of life, the International Classification of Functioning (ICF) for disability, and echographic/ elastosonographic changes of SAT. Significant reductions of pain and circumference measurements were seen in patients at each follow up. This was associated with significant reduction of thickness, echographic pattern improvement, and increased elasticity of SAT, with consequent positive impact on the quality of life and disability reported by the patients. The results demonstrate improved clinical and functional ultrasound findings in patients affected by lipedema in the early stages of lower limbs, and this combination therapy needs to be investigated in larger populations at multiple centers to confirm the findings.
这项试验性研究的目的是调查离焦和径向冲击波疗法、美塑疗法和肌动贴对脂肪性水肿患者的疼痛、下肢周径、皮下脂肪组织(SAT)的回声/弹性声谱图以及生活质量的影响。15名下肢脂肪性水肿二期女性患者接受了冲击波疗法、美塑疗法以及大腿和腿部肌力贴治疗(每周两次,共八次)。治疗的主要结果是疼痛,采用数字评分量表(NRS)进行评估。次要结果包括肢体周长测量、生活质量 SF-12 健康调查、残疾国际功能分类 (ICF) 以及 SAT 的回声/弹力超声变化。在每次随访中,患者的疼痛和周长测量值都有显著下降。这与 SAT 的厚度明显减少、回声模式改善和弹性增加有关,从而对患者的生活质量和残疾报告产生了积极影响。研究结果表明,下肢脂肪性水肿早期患者的临床和功能性超声检查结果均有所改善,这种联合疗法需要在多个中心对更多人群进行研究,以证实研究结果。
{"title":"Defocused and Radial Shock Wave Therapy, Mesotherapy, and Kinesio Taping Effects in Patients with Lipedema: A Pilot Study.","authors":"S. Michelini, F. Musa, M. Vetrano, F. Santoboni, S. M. Nusca, E. Latini, D. Trischitta, S. Michelini, M. Iosa, M. Vulpiani","doi":"10.2458/lymph.5872","DOIUrl":"https://doi.org/10.2458/lymph.5872","url":null,"abstract":"The aim of this pilot study was to investigate the effects of defocused and radial shock wave therapy, mesotherapy, and kinesio taping on pain, circumferences of lower limbs, echographic/ elastosonographic pattern of subcutaneous adipose tissue (SAT), and quality of life in patients with lipedema. Fifteen women affected by lower limb lipedema in stage II were treated with shock wave therapy, mesotherapy, and kinesio taping on thighs and legs (eight sessions, twice a week). The primary outcome was pain, as assessed by Numeric Rating Scale (NRS). Secondary outcomes included the limb circumferences measurements, the SF-12 Health Survey for quality of life, the International Classification of Functioning (ICF) for disability, and echographic/ elastosonographic changes of SAT. Significant reductions of pain and circumference measurements were seen in patients at each follow up. This was associated with significant reduction of thickness, echographic pattern improvement, and increased elasticity of SAT, with consequent positive impact on the quality of life and disability reported by the patients. The results demonstrate improved clinical and functional ultrasound findings in patients affected by lipedema in the early stages of lower limbs, and this combination therapy needs to be investigated in larger populations at multiple centers to confirm the findings.","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"24 1","pages":"13-26"},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139210021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncolymphology: Immune Interactions and Cancer. 肿瘤淋巴学:免疫相互作用与癌症
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-11-29 DOI: 10.2458/lymph.5870
S. P. Leong
The proposed term "oncolymphology" encompasses the intimate relationship between cancer growth and the immune responses.
拟议中的 "肿瘤免疫学 "一词包含了癌症生长与免疫反应之间的密切关系。
{"title":"Oncolymphology: Immune Interactions and Cancer.","authors":"S. P. Leong","doi":"10.2458/lymph.5870","DOIUrl":"https://doi.org/10.2458/lymph.5870","url":null,"abstract":"The proposed term \"oncolymphology\" encompasses the intimate relationship between cancer growth and the immune responses.","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"44 1","pages":"1-2"},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139211429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ISL NEWS ISL 新闻
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-11-29 DOI: 10.2458/lymph.5874
Isl News
ISL NEWS March 2023
ISL 新闻 2023 年 3 月
{"title":"ISL NEWS","authors":"Isl News","doi":"10.2458/lymph.5874","DOIUrl":"https://doi.org/10.2458/lymph.5874","url":null,"abstract":"ISL NEWS March 2023","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"16 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139214794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does Liposuction for Lymphedema Worsen Lymphatic Injury? 淋巴水肿吸脂手术会加重淋巴损伤吗?
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-11-29 DOI: 10.2458/lymph.5871
W. F. Chen, S. K. Pandey, J. N. Lensing
Liposuction for treatment of lymphedema is an effective and time-tested treatment. However, as there is a fear regarding further lymphatic damage caused by liposuction, we objectively compared lymphatic function pre- and post-liposuction. All patients with solid-predominant lymphedema who were treated during the study period of June 2014 and November 2018 were included. Patients were assessed using patient-reported baselines/outcomes, lymphedema- specific quality of life scale (LYMQOL), limb circumference/volume measurements, and indocyanine green lymphography (ICGL) preoperatively and at predefined postoperative time intervals. Fifty-seven limbs from 41 patients were included. Mean lipoaspirate volumes were 2035 mL, 5385 mL, and 3106 mL for the arm, thigh, and leg, respectively with a mean adipose fraction of the lipoaspirate of 71%. All patients underwent redundant skin excision with the "flying squirrel" technique. The mean follow-up was 10.7 months (range 3 - 48 months) with a mean limb volume reduction of 32.2% and all patients reporting satisfactory relief of symptoms. All showed statistically significant improvement in LYMQOL in symptoms, appearance, and function. On ICGL, none showed worsened lymphatic drainage, rather, all showed improved lymph drainage. Furthermore, the improved lymph drainage was found to be progressive during the study period in all patients. Our study results demonstrate that treating extremity lymphedema with liposuction does not worsen lymphatic function and in fact, paradoxically, it induces progressive improvement in lymph drainage.
抽脂治疗淋巴水肿是一种行之有效、久经考验的治疗方法。然而,由于人们担心吸脂会造成进一步的淋巴损伤,我们对吸脂前后的淋巴功能进行了客观比较。研究纳入了在2014年6月至2018年11月期间接受治疗的所有实性淋巴水肿患者。使用患者报告的基线/结果、淋巴水肿特定生活质量量表(LYMQOL)、肢体周长/体积测量值和吲哚菁绿淋巴造影(ICGL)对患者进行术前评估,并在术后预定的时间间隔进行评估。共纳入了 41 名患者的 57 个肢体。手臂、大腿和小腿的平均吸脂量分别为 2035 mL、5385 mL 和 3106 mL,吸脂量中脂肪的平均比例为 71%。所有患者都接受了 "飞鼠 "技术的多余皮肤切除术。平均随访时间为 10.7 个月(3 - 48 个月),平均肢体体积缩小了 32.2%,所有患者都表示症状得到了满意的缓解。所有患者的 LYMQOL 在症状、外观和功能方面均有明显改善。在 ICGL 检查中,所有患者的淋巴引流情况都没有恶化,反而都有所改善。此外,在研究期间,所有患者的淋巴引流情况都在逐渐改善。我们的研究结果表明,用吸脂术治疗肢端淋巴水肿并不会使淋巴功能恶化,事实上,矛盾的是,它还能诱导淋巴引流的逐步改善。
{"title":"Does Liposuction for Lymphedema Worsen Lymphatic Injury?","authors":"W. F. Chen, S. K. Pandey, J. N. Lensing","doi":"10.2458/lymph.5871","DOIUrl":"https://doi.org/10.2458/lymph.5871","url":null,"abstract":"Liposuction for treatment of lymphedema is an effective and time-tested treatment. However, as there is a fear regarding further lymphatic damage caused by liposuction, we objectively compared lymphatic function pre- and post-liposuction. All patients with solid-predominant lymphedema who were treated during the study period of June 2014 and November 2018 were included. Patients were assessed using patient-reported baselines/outcomes, lymphedema- specific quality of life scale (LYMQOL), limb circumference/volume measurements, and indocyanine green lymphography (ICGL) preoperatively and at predefined postoperative time intervals. Fifty-seven limbs from 41 patients were included. Mean lipoaspirate volumes were 2035 mL, 5385 mL, and 3106 mL for the arm, thigh, and leg, respectively with a mean adipose fraction of the lipoaspirate of 71%. All patients underwent redundant skin excision with the \"flying squirrel\" technique. The mean follow-up was 10.7 months (range 3 - 48 months) with a mean limb volume reduction of 32.2% and all patients reporting satisfactory relief of symptoms. All showed statistically significant improvement in LYMQOL in symptoms, appearance, and function. On ICGL, none showed worsened lymphatic drainage, rather, all showed improved lymph drainage. Furthermore, the improved lymph drainage was found to be progressive during the study period in all patients. Our study results demonstrate that treating extremity lymphedema with liposuction does not worsen lymphatic function and in fact, paradoxically, it induces progressive improvement in lymph drainage.","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"43 1","pages":"3-12"},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139211695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can Acupuncture be a Part of the Treatment for Breast Cancer-Related Lymphedema? A Systematic Review of the Safety and Proposed Model for Care. 针灸可以作为乳腺癌相关淋巴水肿治疗的一部分吗?安全性系统回顾及护理模式建议。
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-11-29 DOI: 10.2458/lymph.5873
J. K. Kim, C. Loo, J. S. Kim, C. Pranskevich, O. K. Gordon
Acupuncture is a potential therapy for breast cancer-related lymphedema (BCRL). Despite a recent meta-analysis on efficacy, data on acupuncture safety in BCRL are lacking. Current clinical guidelines recommend avoiding needling in the upper extremity affected by lymph node dissection. We undertook a systematic review focusing on acupuncture safety and treatment protocols in clinical trials for BCRL. Literature searches were conducted in PubMed, Ovid, CINAHL, and Cochrane library. Eight clinical trials on acupuncture for BCRL were analyzed. The Standards of Acupuncture intervention (STRICTA 2010) and Cochrane risk of bias (RoB2 2019) were applied to assess methods for acupuncture interventions within Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework. Quantity and severity of adverse events (AE) were reviewed. A total of 189 subjects participated in 8 clinical trials with 2965 acupuncture treatments. No serious adverse events (SAE) were reported regardless of treatment laterality or protocol, with only a single grade 2 skin infection in 2,965 total treatments (0.034%), including 1,165 bilateral and 225 ipsilateral treatments. Our comprehensive review of clinical trials of acupuncture for BCRL demonstrated no significant adverse events in 2,965 treatments, including 1,390 in the affected limb. An approach for routine integration of acupuncture into BCRL maintenance therapy is proposed.
针灸是治疗乳腺癌相关淋巴水肿(BCRL)的一种潜在疗法。尽管最近有一项关于疗效的荟萃分析,但仍缺乏有关针刺治疗乳腺癌相关淋巴水肿安全性的数据。目前的临床指南建议避免针刺受淋巴结清扫影响的上肢。我们进行了一项系统性综述,重点关注针刺治疗 BCRL 的安全性和临床试验中的治疗方案。我们在 PubMed、Ovid、CINAHL 和 Cochrane 图书馆进行了文献检索。对八项针灸治疗 BCRL 的临床试验进行了分析。针灸干预标准(STRICTA 2010)和Cochrane偏倚风险(RoB2 2019)被应用于系统综述和荟萃分析首选报告项目(PRISMA)框架内的针灸干预评估方法。对不良事件(AE)的数量和严重程度进行了审查。共有 189 名受试者参加了 8 项临床试验,接受了 2965 次针灸治疗。在总计 2965 次治疗(0.034%)中,包括 1165 次双侧治疗和 225 次同侧治疗,无严重不良事件(SAE)报告,仅有一次 2 级皮肤感染(0.034%)。我们对针灸治疗 BCRL 的临床试验进行了全面回顾,结果表明在 2,965 次治疗中,包括 1,390 次患肢治疗,未出现明显的不良事件。我们提出了将针灸纳入 BCRL 维持治疗的常规方法。
{"title":"Can Acupuncture be a Part of the Treatment for Breast Cancer-Related Lymphedema? A Systematic Review of the Safety and Proposed Model for Care.","authors":"J. K. Kim, C. Loo, J. S. Kim, C. Pranskevich, O. K. Gordon","doi":"10.2458/lymph.5873","DOIUrl":"https://doi.org/10.2458/lymph.5873","url":null,"abstract":"Acupuncture is a potential therapy for breast cancer-related lymphedema (BCRL). Despite a recent meta-analysis on efficacy, data on acupuncture safety in BCRL are lacking. Current clinical guidelines recommend avoiding needling in the upper extremity affected by lymph node dissection. We undertook a systematic review focusing on acupuncture safety and treatment protocols in clinical trials for BCRL. Literature searches were conducted in PubMed, Ovid, CINAHL, and Cochrane library. Eight clinical trials on acupuncture for BCRL were analyzed. The Standards of Acupuncture intervention (STRICTA 2010) and Cochrane risk of bias (RoB2 2019) were applied to assess methods for acupuncture interventions within Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework. Quantity and severity of adverse events (AE) were reviewed. A total of 189 subjects participated in 8 clinical trials with 2965 acupuncture treatments. No serious adverse events (SAE) were reported regardless of treatment laterality or protocol, with only a single grade 2 skin infection in 2,965 total treatments (0.034%), including 1,165 bilateral and 225 ipsilateral treatments. Our comprehensive review of clinical trials of acupuncture for BCRL demonstrated no significant adverse events in 2,965 treatments, including 1,390 in the affected limb. An approach for routine integration of acupuncture into BCRL maintenance therapy is proposed.","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"25 1","pages":"27-39"},"PeriodicalIF":2.5,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139210720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Centrifugal Versus Centripetal Origin(s) of the Lymphatic System: Controversy (Mostly) Resolved? 淋巴系统的离心起源与向心起源:争议(大部分)解决了?
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-08-07 DOI: 10.2458/lymph.5735
M. Witte, R. Erickson
New findings reopen the controversy about centrifugal vs. centripetal origin of the lymphatic system and support that the latter may be the predominant source of lymphatic endothelial cells from mesenchymal lymphangioblasts.
新的发现重新引发了关于淋巴系统离心起源与向心起源的争议,并支持后者可能是间充质淋巴管母细胞淋巴内皮细胞的主要来源。
{"title":"Centrifugal Versus Centripetal Origin(s) of the Lymphatic System: Controversy (Mostly) Resolved?","authors":"M. Witte, R. Erickson","doi":"10.2458/lymph.5735","DOIUrl":"https://doi.org/10.2458/lymph.5735","url":null,"abstract":"New findings reopen the controversy about centrifugal vs. centripetal origin of the lymphatic system and support that the latter may be the predominant source of lymphatic endothelial cells from mesenchymal lymphangioblasts.","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"55 4 1","pages":"141-143"},"PeriodicalIF":2.5,"publicationDate":"2023-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45820223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Various Clinical Scenarios in Secondary Malignant Lymphedema. 继发性恶性淋巴水肿的各种临床表现。
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-08-07 DOI: 10.2458/lymph.5736
I. Forner-Cordero, L. Herrero-Manley, R. García-Marcos, J. Muñoz-Langa
Diagnosing malignant lymphedema is a challenge in daily clinical practice. Clinically, patients may show clear signs of malignancy, but this is not always the case, and at times the diagnosis is not straightforward. In some patients, pain, hardness of the tissues, joint stiffness, proximal involvement, collateral circulation, or an acute onset will provide the clue to determining malignancy. Our aim is to describe several diverse scenarios of Secondary Malignant Lymphedema (SML) with the etiopathogenesis. One possible cause is lymphatic obstruction due to extrinsic compression of lymphatic vessels and/or nodes by either the primary tumor or metastatic masses. Lymphatic obstruction can also be caused by tumoral infiltration. This infiltration can affect both deep and regional nodes as well as cutaneous and subcutaneous vessels and is commonly known as lymphangitis carcinomatosa. Malignant lymphedema can also be secondary to obstruction of the venous flow due to tumoral venous thromboembolism or to extrinsic compression of the veins by tumors or adenopathic masses. Nevertheless, the most frequent cause of this illness is a mixed mechanism of compression of the lymphatic and venous systems. Frequently, SML is the first manifestation of relapse. When lymphedema appears abruptly, is progressive, with intense pain, associated with collateral circulation, or with hard and infiltrated skin or joint stiffness, SML must be ruled out with an urgent referral to the oncologist and an imaging evaluation.
诊断恶性淋巴水肿是一个挑战,在日常临床实践。临床上,患者可能表现出明显的恶性肿瘤迹象,但情况并非总是如此,有时诊断并不直截了当。在一些患者中,疼痛、组织硬度、关节僵硬、近端受累、侧支循环或急性发作将提供确定恶性肿瘤的线索。我们的目的是描述继发性恶性淋巴水肿(SML)的几种不同的情况与发病机制。一个可能的原因是由于原发肿瘤或转移性肿块对淋巴管和/或淋巴结的外在压迫而造成的淋巴阻塞。淋巴阻塞也可由肿瘤浸润引起。这种浸润可以影响深层和局部淋巴结以及皮肤和皮下血管,通常被称为癌性淋巴管炎。恶性淋巴水肿也可继发于因肿瘤静脉血栓栓塞引起的静脉流动阻塞,或继发于肿瘤或腺病肿块对静脉的外在压迫。然而,这种疾病最常见的原因是淋巴和静脉系统受压的混合机制。通常,SML是复发的第一个表现。当淋巴水肿突然出现,呈进行性,伴有剧烈疼痛,伴有侧支循环,或伴有皮肤坚硬和浸润性或关节僵硬时,必须排除SML,立即转诊至肿瘤科医生并进行影像学评估。
{"title":"Various Clinical Scenarios in Secondary Malignant Lymphedema.","authors":"I. Forner-Cordero, L. Herrero-Manley, R. García-Marcos, J. Muñoz-Langa","doi":"10.2458/lymph.5736","DOIUrl":"https://doi.org/10.2458/lymph.5736","url":null,"abstract":"Diagnosing malignant lymphedema is a challenge in daily clinical practice. Clinically, patients may show clear signs of malignancy, but this is not always the case, and at times the diagnosis is not straightforward. In some patients, pain, hardness of the tissues, joint stiffness, proximal involvement, collateral circulation, or an acute onset will provide the clue to determining malignancy. Our aim is to describe several diverse scenarios of Secondary Malignant Lymphedema (SML) with the etiopathogenesis. One possible cause is lymphatic obstruction due to extrinsic compression of lymphatic vessels and/or nodes by either the primary tumor or metastatic masses. Lymphatic obstruction can also be caused by tumoral infiltration. This infiltration can affect both deep and regional nodes as well as cutaneous and subcutaneous vessels and is commonly known as lymphangitis carcinomatosa. Malignant lymphedema can also be secondary to obstruction of the venous flow due to tumoral venous thromboembolism or to extrinsic compression of the veins by tumors or adenopathic masses. Nevertheless, the most frequent cause of this illness is a mixed mechanism of compression of the lymphatic and venous systems. Frequently, SML is the first manifestation of relapse. When lymphedema appears abruptly, is progressive, with intense pain, associated with collateral circulation, or with hard and infiltrated skin or joint stiffness, SML must be ruled out with an urgent referral to the oncologist and an imaging evaluation.","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"55 4 1","pages":"144-154"},"PeriodicalIF":2.5,"publicationDate":"2023-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46825670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ISL NEWS ISL的新闻
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-08-07 DOI: 10.2458/lymph.5740
Isl News
ISL NEWS December 2022
ISL新闻2022年12月
{"title":"ISL NEWS","authors":"Isl News","doi":"10.2458/lymph.5740","DOIUrl":"https://doi.org/10.2458/lymph.5740","url":null,"abstract":"ISL NEWS December 2022","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"1 1","pages":""},"PeriodicalIF":2.5,"publicationDate":"2023-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44951703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upper Limb Lymphedema Impacts the Risk of Peripherally Inserted Central Catheter-Related Thrombosis in Patients with Breast Cancer. 癌症患者上肢淋巴水肿影响外周穿刺中心导管相关血栓形成的风险。
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-08-07 DOI: 10.2458/lymph.5739
T. Wei, Si‐yi Peng, X-Y Li, Z. Yuan, Q. Lin
There is little information on the risk for catheter-related thrombosis in patients with upper limb lymphedema following breast cancer treatment. We investigated the association between upper limb lymphedema and the risk of peripherally inserted central catheterrelated thrombosis (PICC-RT) occurring in the contralateral limb of patients with breast cancer. A retrospective review analyzed all patients with breast cancer who underwent PICC insertion at a cancer hospital in Hunan Province from 2015 to 2019. Upper limb lymphedema was indexed from hospital information system (HIS) before the occurrence of PICC-RT developed in the contralateral limb. Cox regression analysis was used to evaluate the association of factors with outcome. A total of 1,262 patient records were found and 50 cases of PICC-RT were identified. Forty of these occurred in patients without lymphedema (n=1,236) and 10 in patients with upper limb lymphedema (n=26). After adjustment for various co-variables, Cox regression analysis showed that upper limb lymphedema was significantly associated with increased risk of PICC-RT (hazard ratio=12.128, 95% confidence interval=5.551-26.501; P<0.001). In breast cancer patients, upper limb lymphedema may be an important predictor for PICC-RT in the contralateral limb and information should be provided to patients.
关于乳腺癌治疗后上肢淋巴水肿患者导管相关血栓形成风险的信息很少。我们研究了乳腺癌患者对侧肢体上肢淋巴水肿与外周插入性中心导管相关血栓形成(PICC-RT)风险之间的关系。一项回顾性研究分析了2015年至2019年在湖南省某肿瘤医院接受PICC插入的所有乳腺癌患者。在对侧肢体出现PICC-RT之前,通过医院信息系统(HIS)对上肢淋巴水肿进行索引。采用Cox回归分析评价各因素与预后的相关性。共发现1262例病例,其中PICC-RT确诊病例50例。其中40例发生在无淋巴水肿患者(n=1,236), 10例发生在上肢淋巴水肿患者(n=26)。校正各协变量后,Cox回归分析显示上肢淋巴水肿与PICC-RT风险增加显著相关(风险比=12.128,95%可信区间=5.551-26.501;P < 0.001)。在乳腺癌患者中,上肢淋巴水肿可能是对侧肢体PICC-RT的重要预测指标,应向患者提供相关信息。
{"title":"Upper Limb Lymphedema Impacts the Risk of Peripherally Inserted Central Catheter-Related Thrombosis in Patients with Breast Cancer.","authors":"T. Wei, Si‐yi Peng, X-Y Li, Z. Yuan, Q. Lin","doi":"10.2458/lymph.5739","DOIUrl":"https://doi.org/10.2458/lymph.5739","url":null,"abstract":"There is little information on the risk for catheter-related thrombosis in patients with upper limb lymphedema following breast cancer treatment. We investigated the association between upper limb lymphedema and the risk of peripherally inserted central catheterrelated thrombosis (PICC-RT) occurring in the contralateral limb of patients with breast cancer. A retrospective review analyzed all patients with breast cancer who underwent PICC insertion at a cancer hospital in Hunan Province from 2015 to 2019. Upper limb lymphedema was indexed from hospital information system (HIS) before the occurrence of PICC-RT developed in the contralateral limb. Cox regression analysis was used to evaluate the association of factors with outcome. A total of 1,262 patient records were found and 50 cases of PICC-RT were identified. Forty of these occurred in patients without lymphedema (n=1,236) and 10 in patients with upper limb lymphedema (n=26). After adjustment for various co-variables, Cox regression analysis showed that upper limb lymphedema was significantly associated with increased risk of PICC-RT (hazard ratio=12.128, 95% confidence interval=5.551-26.501; P<0.001). In breast cancer patients, upper limb lymphedema may be an important predictor for PICC-RT in the contralateral limb and information should be provided to patients.","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"55 4 1","pages":"178-187"},"PeriodicalIF":2.5,"publicationDate":"2023-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47153322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manual Lymphatic Drainage Increases the Number of Opened Lymphatic Pathways in Patients with Lower Limb Lymphedemas: A Sequential Research on 80 Patients. 手动淋巴引流增加下肢淋巴水肿患者开放淋巴通路的数量:80例患者的序贯研究
IF 2.5 4区 医学 Q4 IMMUNOLOGY Pub Date : 2023-08-07 DOI: 10.2458/lymph.5737
R. Barbieux, M. Roman, D.R.Y. Penafuerte, O. Leduc, A. Leduc, P. Bourgeois, S. Provyn
The purpose of this study was to lymphoscintigraphically assess the effect of skin mobilization, nonspecific massage, and manual lymphatic drainage (MLD) on the root of the lower limb in patients with lower limb lymphedema. Lower limb root lymphoscintigraphical exams of 80 patients with lower limb lymphedema were analyzed. All patients underwent our stand 3 phase protocol and then were subjected to the 4th phase which included 3 subphases. Images were taken directly after the injection (subphase 1), after pinching and stretching the injection site (subphase 2), after nonspecific massage was applied to the injected site (subphase 3) and after manual lymphatic drainage of the injected site (subphase 4). The number of opened lymphatic pathways was analyzed and compared after and between each subphase (SP). SP 1 displayed open lymphatic pathways in 22 of the 80 cases (27.5%). SP 2 displayed newly opened lymphatic pathways in 48 of the 80 cases (60.0%). SP 3 displayed newly opened lymphatic pathways in 57 of the 80 cases (71.3%). Only 9 of these 57 cases did not show improvement following the next SP. SP 4 displayed newly opened lymphatic pathways in 60 of the 80 cases (75.1%). MLD improved the visualization of the lymphatic pathways in 48 cases (60%) compared to phase 3. MLD was the only technique to allow visualization of the lymphatic drainage at the level of the root of the edematous limb in 6 cases (7.5%). Physical therapy leads to a greater number of lymphatic collaterals opening in a region where no other complex decongestive therapy technique can be applied.
本研究的目的是淋巴显像评估皮肤动员、非特异性按摩和手动淋巴引流(MLD)对下肢淋巴水肿患者下肢根部的影响。对80例下肢淋巴水肿患者下肢根淋巴影像学检查结果进行分析。所有患者都接受了我们的3期方案,然后进行了包括3个亚期的第4期。分别在注射后(亚期1)、按压拉伸注射部位(亚期2)、非特异性按摩注射部位(亚期3)和手工引流注射部位淋巴后(亚期4)直接拍照。分析比较各亚期后和亚期间开放淋巴通路的数量。80例患者中有22例(27.5%)表现为淋巴通路开放。80例患者中48例(60.0%)SP 2显示新开辟的淋巴通路。80例sp3患者中57例(71.3%)出现新开辟的淋巴通路。57例患者中只有9例在下一次SP治疗后没有改善。80例患者中有60例(75.1%)出现新开通的淋巴管。与第三期相比,MLD改善了48例(60%)患者淋巴通路的可视化。在6例(7.5%)患者中,MLD是唯一能显示水肿肢体根部淋巴引流的技术。物理治疗导致更多的淋巴络在没有其他复杂的消血治疗技术可以应用的区域打开。
{"title":"Manual Lymphatic Drainage Increases the Number of Opened Lymphatic Pathways in Patients with Lower Limb Lymphedemas: A Sequential Research on 80 Patients.","authors":"R. Barbieux, M. Roman, D.R.Y. Penafuerte, O. Leduc, A. Leduc, P. Bourgeois, S. Provyn","doi":"10.2458/lymph.5737","DOIUrl":"https://doi.org/10.2458/lymph.5737","url":null,"abstract":"The purpose of this study was to lymphoscintigraphically assess the effect of skin mobilization, nonspecific massage, and manual lymphatic drainage (MLD) on the root of the lower limb in patients with lower limb lymphedema. Lower limb root lymphoscintigraphical exams of 80 patients with lower limb lymphedema were analyzed. All patients underwent our stand 3 phase protocol and then were subjected to the 4th phase which included 3 subphases. Images were taken directly after the injection (subphase 1), after pinching and stretching the injection site (subphase 2), after nonspecific massage was applied to the injected site (subphase 3) and after manual lymphatic drainage of the injected site (subphase 4). The number of opened lymphatic pathways was analyzed and compared after and between each subphase (SP). SP 1 displayed open lymphatic pathways in 22 of the 80 cases (27.5%). SP 2 displayed newly opened lymphatic pathways in 48 of the 80 cases (60.0%). SP 3 displayed newly opened lymphatic pathways in 57 of the 80 cases (71.3%). Only 9 of these 57 cases did not show improvement following the next SP. SP 4 displayed newly opened lymphatic pathways in 60 of the 80 cases (75.1%). MLD improved the visualization of the lymphatic pathways in 48 cases (60%) compared to phase 3. MLD was the only technique to allow visualization of the lymphatic drainage at the level of the root of the edematous limb in 6 cases (7.5%). Physical therapy leads to a greater number of lymphatic collaterals opening in a region where no other complex decongestive therapy technique can be applied.","PeriodicalId":51122,"journal":{"name":"Lymphology","volume":"55 4 1","pages":"155-166"},"PeriodicalIF":2.5,"publicationDate":"2023-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43855635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lymphology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1